Mayne’s Generics Segment Sees Double-Digit Drop In Sales

Company Expects NuvaRing Generic And Pipeline Products To Drive Growth

Covid19_Economic_Fallout
Despite the impact of COVID-19, Mayne has put together a plan to stabilize its generics segment. • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Generics

More from Products